MGH opens first-of-its-kind center to eliminate lifelong immunosuppression after organ transplant

Reviewed by Lily Ramsey, LLM

Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health system, officially opened the Legorreta Center for Clinical Transplant Tolerance, the first-of-its kind center in the world dedicated to preventing organ rejection after transplant surgery without the use of lifelong immunosuppressive medications. Immunosuppressive medications prevent the immune system from rejecting a transplanted organ, but come with serious side effects, increasing the chance of infections and other illnesses like cancer, diabetes, and heart disease. Read the complete article in News Medical Life Sciences.